Anacor Reworks Collaboration With GSK For Potential Of Additional LeuRS Antibiotics
This article was originally published in The Pink Sheet Daily
Executive Summary
Six-year deal signed in 2007 may be extended if GSK decides to option additional leucyl-tRNA synthetase candidates discovered by Anacor.